Gara Jalqabaatti › Makroglobulinemiyaa Waldenstrom › Massachusetts › Boston
Qorannoo klinikaalii Makroglobulinemiyaa Waldenstrom Boston, MA keessatti
Qorannoo 9 Makroglobulinemiyaa Waldenstrom f Boston fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)
Namoota walitti qabaa jiraSadarkaa 2
- Dana Farber Cancer Institute (Data Collection and Specimen Analysis), Boston
- Beth Israel Deaconess Medical Center (Data Collection Only), Boston
A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Dana Farber Cancer Institute, Boston
A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )
Namoota walitti qabaa jiraSadarkaa 1
- Massachusetts General Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM
Namoota walitti qabaa jiraSadarkaa 2
- Massachusetts General Hospital, Boston
- Beth Israel Deaconess Medical Center, Boston
- Dana Farber Cancer Institute, Boston
Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy
Namoota walitti qabaa jiraSadarkaa 4
- Brigham and Women's Hospital, Boston
- Dana-Farber Cancer Institute, Boston
Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome
Namoota walitti qabaa jiraQorannoo ilaalaa
- Dana-Farber Cancer Institute, Boston
Epcoritamab in Previously Treated WM
Namoota walitti qabaa jiraSadarkaa 2
- Beth Israel Deaconess Medical Center, Boston
- Dana-Farber Cancer Institute, Boston
Study of SGR-1505 in Mature B-Cell Neoplasms
Namoota walitti qabaa jiraSadarkaa 1
- Beth Israel Deaconess Medical Center, Boston
A Phase 2 Study to Evaluate the Safety and Efficacy of Pacritinib in Relapsed or Refractory Waldenström Macroglobulinemia
Namoota walitti qabaa jiraSadarkaa 2
- Dana Farber Cancer Institute, Boston
Qorannoo Makroglobulinemiyaa Waldenstrom magaalota biroo keessatti
- Durham, NCQorannoo 10
- Denver, COQorannoo 7
- New York City, NYQorannoo 6
- Edison, NJQorannoo 6
- Dallas, TXQorannoo 6
- Houston, TXQorannoo 6
- Seattle, WAQorannoo 5
- Rochester, MNQorannoo 5
- Milwaukee, WIQorannoo 5
- Queens, NYQorannoo 4
- Columbus, OHQorannoo 4
- Baldwin Park, CAQorannoo 4
Qorannoo biroo Boston keessatti
- Saree OljooQorannoo 111
- Kansara Qara'a Non-Small CellQorannoo 90
- Saree (Gosoota Hunda)Qorannoo 86
- Kansarii ColorectalQorannoo 63
- Kansara MetastatikiiQorannoo 63
- Dhibee QaraQorannoo 62
- Kansarii OvariiQorannoo 61
- Kansarii ProstateQorannoo 59
- DepreshiniiQorannoo 52
- Kansa EndometiriyaaliiQorannoo 50
- Cufama OnneeQorannoo 44
- Leukemia Myeloidii HamaaQorannoo 44
Kanneen ClinicalTrials.gov irraa argaman, daataa 05-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.